JAY BUDREWICZ ScM, LATg, SRT – Study Director

CELEBRATING 14 YEARS AT CBSET…In his role as a preclinical Study Director, Jay is responsible for a quality system ensuring that safety studies at CBSET are duly designed, conducted, and documented to generate reliable data. As a Scientist II, he manages associate scientists, coordinates study planning, provides technical guidance and performs surgical procedures. Jay himself […]

DR. NICOLA M. PARRY Bsc, Msc, BVSc, DACVP, FRCVS – CBSET DIRECTOR OF PATHOLOGY OPERATIONS

CELEBRATING HER FIRST YEAR WITH CBSET… Dr. Nicola Parry is a Diplomate of the American College of Veterinary Pathologists (ACVP). She comes to CBSET from Massachusetts Institute of Technology (MIT) where she was Chief of Comparative Pathology, managing research and diagnostic pathology support for both in­ house and external research groups. Prior to MIT, Dr. […]

DAVID PARRILLO, MBA – CBSET SR. ACCOUNT EXEC., BUSINESS DEVELOPMENT

CELEBRATING 5 YEARS AT CBSET…David joined CBSET in 2017 as Senior Account Executive for Business Development. He has 30 years of biotech and pharma sales experience in therapeutic areas ranging from cardiology, infertility, and oncology to allergy/immunology and patient-reported outcomes. Previous employers include Bristol Meyers Squibb, EMD Serono and Schering-Plough, working within the major academic […]

DONALD HODGES, PhD, MSc, DSP – Study Director

CELEBRATING 3 YEARS AT CBSET…A neuroscientist and safety pharmacologist with expertise in behavioral assessments, Dr. Hodges is toxicology study director for small-molecule and biologic preclinical therapeutic research at CBSET. In this role, he advises Sponsors about in vivo preclinical study design and FDA expectations. In particular, he assists Sponsors in developing safety assessment studies, including regulatory […]

MISTY WILLIAMS-FRITZE, DVM, MS, DACLAM – CBSET VP OF VETERINARY SERVICES & TECHNICAL OPERATIONS

CELEBRATING 11 YEARS AT CBSET… Dr. Williams-Fritze joined CBSET in 2012. She is responsible for developing surgical models, performing procedures to meet Sponsors’ needs and ensuring regulatory compliance with applicable agencies, and overall management of the vivarium and oversight and training of CBSET’s technical staff. THREE THINGS YOU SHOULD KNOW ABOUT DR. MISTY WILLIAMS-FRITZE 1: […]

MICHAEL NAIMARK, MS – CBSET DIRECTOR OF BUSINESS DEVELOPMENT

CELEBRATING 6 YEARS AT CBSET… Michael joined CBSET in 2016 as Director of Business Development, bringing significant biomedical experience and specialized expertise to the role. Previously, he was employed by Neural Stem Cell Institute (NSCI), where he oversaw development of a cell-based therapy for macular degeneration under an award from the New York Stem Cell […]

RAMI TZAFRIRI, PhD – CBSET DIRECTOR OF RESEARCH & INNOVATION

SINCE 2009…Dr. Rami Tzafriri has provided scientific leadership to CBSET’s cutting-edge translational research programs, leveraging CBSET’s strengths in minimally invasive interventions, histopathology, imaging, bioanalysis and computational modeling to accelerate product development. He also leads CBSET’s educational and technology differentiations mission, and liaises with key opinion leaders. THREE THINGS YOU SHOULD KNOW ABOUT DR. RAMI TZAFRIRI […]

DR. JOHN KEATING, DVM, DACVP – CBSET DIRECTOR OF PATHOLOGY

CELEBRATING 12 YEARS AT CBSET… Dr. John Keating is a Diplomate of the American College of Veterinary Pathology, with years of experience in contract research and preclinical safety evaluations, including gross and microscopic pathology, pathophysiology, specialized staining, and imaging procedures across a variety of device classes and large- and small-animal species, and is well-versed in […]

PETER M. MARKHAM, MS – CBSET PRESIDENT, CEO, CO-FOUNDER

CELEBRATING 16 YEARS AT CBSET… With broad scientific expertise in both drug and device development, Peter co-founded CBSET in 2006 and, as its CEO, has since led the way in establishing CBSET as the undisputed gold standard for preclinical science in the life sciences industry. THREE THINGS YOU SHOULD KNOW ABOUT PETER M. MARKHAM 1: […]